Last update 16 May 2025

RO-7565020

Overview

Basic Info

Drug Type
Biological products
Synonyms
RO 7565020, RO7565020
Target-
Action-
Mechanism-
Therapeutic Areas
Infectious DiseasesDigestive System Disorders
Active Indication
Hepatitis B, Chronic
Inactive Indication-
Originator Organization
Roche Holding AGRoche Holding AG
Active Organization
F. Hoffmann-La Roche Ltd.
Inactive Organization
Roche R & D Center China Co. Ltd.Roche R & D Center China Co. Ltd.Roche Holding AGRoche Holding AG
License Organization-
Drug Highest PhaseIND Approval
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with RO-7565020
CTIS2022-502579-46-00
/ Not yet recruitingPhase 1
- BP44118
NCT05763576
/ TerminatedPhase 1
A Phase I Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7565020 in Healthy Participants and in Participants With Chronic Hepatitis B Virus Infection
100 Clinical Results associated with RO-7565020
Login to view more data
100 Translational Medicine associated with RO-7565020
Login to view more data
100 Patents (Medical) associated with RO-7565020
Login to view more data
100 Deals associated with RO-7565020
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatitis B, ChronicPhase 1
United States
Roche R & D Center China Co. Ltd.Roche R & D Center China Co. Ltd.
17 Apr 2023
Hepatitis B, ChronicPhase 1
United States
F. Hoffmann-La Roche Ltd.
17 Apr 2023
Hepatitis B, ChronicPhase 1
Bulgaria
Roche R & D Center China Co. Ltd.Roche R & D Center China Co. Ltd.
17 Apr 2023
Hepatitis B, ChronicPhase 1
Bulgaria
F. Hoffmann-La Roche Ltd.
17 Apr 2023
Hepatitis B, ChronicPhase 1
France
F. Hoffmann-La Roche Ltd.
17 Apr 2023
Hepatitis B, ChronicPhase 1
France
Roche R & D Center China Co. Ltd.Roche R & D Center China Co. Ltd.
17 Apr 2023
Hepatitis B, ChronicPhase 1
New Zealand
F. Hoffmann-La Roche Ltd.
17 Apr 2023
Hepatitis B, ChronicPhase 1
New Zealand
Roche R & D Center China Co. Ltd.Roche R & D Center China Co. Ltd.
17 Apr 2023
Hepatitis B, ChronicPhase 1
South Korea
Roche R & D Center China Co. Ltd.Roche R & D Center China Co. Ltd.
17 Apr 2023
Hepatitis B, ChronicPhase 1
South Korea
F. Hoffmann-La Roche Ltd.
17 Apr 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free